|
Danese E, Raimondi S, Montagnana M, Tagetti A, Langaee T, Borgiani P, Ciccacci C, Carcas AJ, Borobia AM, Tong HY, Davila-Fajardo C, Rodrigues Botton M, Bourgeois S, Deloukas P, Caldwell MD, Burmester JK, Berg RL, Cavallari LH, Drozda K, Huang M, Zhao LZ, Cen HJ, Gonzalez-Conejero R, Roldan V, Nakamura Y, Mushiroda T, Gong IY, Kim RB, Hirai K, Itoh K, Isaza C, Beltran L, Jimenez-Varo E, Canadas-Garre M, Giontella A, Kringen MK, Haug KBF, Gwak HS, Lee KE, Minuz P, Lee MTM, Lubitz SA, Scott S, Mazzaccara C, Sacchetti L, Genc E, Ozer M, Pathare A, Krishnamoorthy R, Paldi A, Siguret V, Loriot MA, Kutala VK, Suarez-Kurtz G, Perini J, Denny JC, Ramirez AH, Mittal B, Rathore SS, Sagreiya H, Altman R, Shahin MHA, Khalifa SI, Limdi NA, Rivers C, Shendre A, Dillon C, Suriapranata IM, Zhou HH, Tan SL, Tatarunas V, Lesauskaite V, Zhang Y, Maitland-van der Zee AH, Verhoef TI, de Boer A, Taljaard M, Zambon CF, Pengo V, Zhang JE, Pirmohamed M, Johnson JA, Fava C. Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals. Clin Pharmacol Ther. 2019 Jun;105(6):1477-1491. doi: 10.1002/cpt.1323. Epub 2019 Feb 17. PubMed PMID: 30506689; PubMed Central PMCID: PMC6542461.
AÑO: 2019; IF: 6.565
|
30506689
|
Lozano ML, Garabet L, Fernandez-Perez MP, De Los Reyes-Garcia AM, Diaz-Lozano P, Garcia-Barbera N, Aguila S, Vicente V, Ghanima W, Martinez C, Gonzalez-Conejero R. Platelet activation and neutrophil extracellular trap (NET) formation in immune thrombocytopenia: is there an association? Platelets. 2020 Oct 2;31(7):906-912. doi: 10.1080/09537104.2019.1696456. Epub 2019 Nov 24. PubMed PMID: 31762368.
AÑO: 2020; IF: 3.862
|
|
Garabet L, Henriksson CE, Lozano ML, Ghanima W, Bussel J, Brodin E, Fernandez-Perez MP, Martinez C, Gonzalez-Conejero R, Mowinckel MC, Sandset PM. Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists. Thromb Res. 2020 Jan;185:119-124. doi: 10.1016/j.thromres.2019.11.031. Epub 2019 Nov 30. PubMed PMID: 31805421.
AÑO: 2020; IF: 3.944
|
|
Ferrer-Marin F, Arroyo AB, Bellosillo B, Cuenca EJ, Zamora L, Hernandez-Rivas JM, Hernandez-Boluda JC, Fernandez-Rodriguez C, Luno E, Garcia Hernandez C, Kerguelen A, Fiallo-Suarez DV, Gomez-Casares MT, Ayala R, Velez P, Boque C, Garcia-Gutierrez V, Arrizabalaga B, Estrada N, Cifuentes R, Arcas I, de Los Reyes-Garcia AM, Besses C, Vicente V, Alvarez-Larran A, Teruel-Montoya R, Gonzalez-Conejero R, Martinez C; GEMFIN Group. miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk. Leukemia. 2020 Oct;34(10):2648-2659. doi: 10.1038/s41375-020-0767-3. Epub 2020 Feb 27. PubMed PMID: 32107471.
AÑO: 2020; IF: 13.4
|
|
Arroyo AB, Fernandez-Perez MP, Del Monte A, Aguila S, Mendez R, Hernandez-Antolin R, Garcia-Barber N, de Los Reyes-Garcia AM, Gonzalez-Jimenez P, Arcas MI, Vicente V, Menendez R, Andres V, Gonzalez-Conejero R, Martinez C. miR-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis. Haematologica. 2021 Jun 1;106(6):1636-1646. doi: 10.3324/haematol.2019.240226. PubMed PMID: 32586906; PubMed Central PMCID: PMC8168495.
AÑO: 2021; IF: 11.047
|